Dabigatran etexilate in people with atrial fibrillation

BMJ (Online)

Volumn 341, Issue 7775, 2010, Pages 682-683

  Raju, Nina C ^a   Hankey, Graeme J ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APIXABAN; CLOPIDOGREL; DABIGATRAN ETEXILATE; EDOXABAN; PLACEBO; RIVAROXABAN; UNCLASSIFIED DRUG; WARFARIN;

ANTICOAGULATION; BLEEDING; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL TRIAL; CREATININE CLEARANCE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; EDITORIAL; EMBOLISM; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIVER TOXICITY; LOW DRUG DOSE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOEMBOLISM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; HUMANS; PYRIDINES; STROKE;

EID: 77957368754     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c3784     Document Type: Editorial

References (9)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;2:983-8.
2. DeWilde S, Carey IM, Emmas C, Richards N, Cook DG. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 2006;92;1064-70. (Pubitemid 44131331)
3. Lin HJ, Wolk PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27:1760-4. [Abstract/FREE Full text] (Pubitemid 26332500)
4. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predictin g stroke. Results from the national registry of atrial fibrillation. JAMA 2001;285:2864-70. [Abstract/FREE Full text] (Pubitemid 32537350)
5. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients whohave nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857 [Abstract/FREE Full text]
6. Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009;360:2066-78. [Abstract/FREE Full text]
7. Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006;367:1903-12. [CrossRef] [Medline] [Web of Science]
8. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidenced-Based Clinical Practice Guidelines (8th edition). Chest 2008;1333:546S.
9. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. [Abstract/FREE Full text]